BiondVax Pharmaceuticals Ltd.
BVXV · NASDAQ
6/30/2023 | 3/31/2023 | 12/31/2022 | 9/30/2022 | |
|---|---|---|---|---|
| Operating Activities | – | – | – | – |
| Net Income | -$4 | -$4 | $27 | – |
| Dep. & Amort. | $0 | $0 | -$1 | – |
| Deferred Tax | -$1 | $0 | $0 | – |
| Stock-Based Comp. | $0 | $0 | $0 | – |
| Change in WC | -$1 | $0 | -$3 | – |
| Other Non-Cash | $2 | -$0 | -$2 | – |
| Operating Cash Flow | -$3 | -$3 | $16 | – |
| Investing Activities | – | – | – | – |
| PP&E Inv. | -$0 | -$0 | -$0 | – |
| Net Acquisitions | $0 | $0 | $0 | – |
| Inv. Purchases | $0 | $0 | $0 | – |
| Inv. Sales/Matur. | $0 | $0 | $0 | – |
| Other Inv. Act. | $0 | $0 | $0 | – |
| Investing Cash Flow | -$0 | -$0 | -$0 | – |
| Financing Activities | – | – | – | – |
| Debt Repay. | $0 | $0 | $0 | – |
| Stock Issued | $0 | $0 | -$28 | – |
| Stock Repurch. | $0 | $0 | $1 | – |
| Dividends Paid | $0 | $0 | $0 | – |
| Other Fin. Act. | $0 | $0 | -$26 | – |
| Financing Cash Flow | $0 | $0 | -$26 | – |
| Forex Effect | -$0 | -$0 | -$2 | – |
| Net Chg. in Cash | -$3 | -$3 | -$13 | – |
| Supplemental Information | – | – | – | – |
| Beg. Cash | $11 | $14 | $39 | – |
| End Cash | $8 | $11 | $27 | – |
| Free Cash Flow | -$3 | -$3 | $15 | – |